ImmunityBio, Inc. IBRX
ImmunityBio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 12,571,597 | $96.4M | 1.24% |
| BlackRock Finance, Inc. | 11,423,089 | $72.2M | 1.13% |
| CITADEL ADVISORS LLC | 5,135,878 | $39.4M | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 4,385,500 | $33.6M | 0.43% |
| MILLENNIUM MANAGEMENT LLC | 1,444,044 | $11.1M | 0.14% |
| Point72 Asset Management, L.P. | 160,100 | $1.2M | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 66,547 | $510,415 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.